With Pressure From Activist Investor, Enhabit Reveals More Details Around Its Strategic Review

With pressure from an activist investor, Enhabit Inc. (NYSE: EHAB) has released more information surrounding its strategic review, which was completed earlier this month. Instead of a merger or sale, the Dallas-based home health and hospice company elected to remain an independent, public company. The activist investor, AREX Capital Management, previously said a sale was […]

Addus Announces Sale Of Its Personal Care Business In New York

Addus HomeCare Corporation (Nasdaq: ADUS) is selling its New York personal care business, along with its fiscal intermediary services for the state’s consumer-directed care program. The company announced Tuesday that it will offload its New York operations to HCS-Girling, another home-based care provider. The divestment will be worth “up to” $23 million for Addus, the […]

Androscoggin Home Healthcare + Hospice Rebrands To ‘Andwell Health Partners’

The Maine-based Androscoggin Home Healthcare + Hospice is rebranding to “better reflect its evolutions and future,” and will be operating under the name Andwell Health Partners moving forward. “As we continue to grow and evolve, we realized that the name Androscoggin Home Healthcare and Hospice no longer accurately reflected who we are, where we are […]

Pennant Announces 2 New Home Health, Hospice Acquisitions; Family Resource Home Care Expands Footprint

The Pennant Group secures 2 more acquisitions The Pennant Group has completed two acquisitions thus far in May. Announced first was its acquisition of the Davis County, Utah-based South Davis Home Health and South Davis Hospice. “This acquisition provides us with an opportunity to further expand in the state of Utah, and will complement our […]

Why Humana Chose Jim Rechtin As Its Next CEO

Humana Inc. (NYSE: HUM) announced Monday that Jim Rechtin would be succeeding Bruce Broussard in the CEO role on July 1. On Tuesday, Broussard explained why. Ultimately, the CEO succession plan had been in place at Humana for a while. Broussard has served in the CEO chair since 2013, and Rechtin was named his successor […]